(PharmaNewsWire.Com, March 20, 2021 ) The report "Operating Room/OR Integration Market by Component (Software, Services), Application (General Surgery, Orthopedic Surgery, Cardiovascular Surgery, Neurosurgery, Thoracic Surgery), End-User (Hospitals, ASC), Region - Global Forecast to 2024" The operating room integration market is projected to grow at a CAGR of 12.4% during the forecast period, to reach USD 1.7 billion by 2024 from USD 1.0 billion in 2019. Factors such as the increasing adoption of minimally invasive surgical procedures, redevelopment projects & funding for improving OR infrastructure, and rising need to curtail healthcare costs are driving the growth of the operating room integration market during the forecast period.
Browse 117 market data Tables and 25 Figures spread through 132 Pages and in-depth TOC on "Operating Room/OR Integration Market - Global Forecast to 2024"
The software segment accounted for the largest share of the operating room integration market, by component, in 2018
The software segment accounted for the largest share of the operating room integration market in 2018. OR integration software helps streamline surgical workflows by enabling seamless communication between different systems as well as ensuring the effective and easier operation of these systems, preferably from a single source. Moreover, operating room integration software helps reduce surgical times, improves coordination between healthcare providers, and improves patient safety.
General surgery segment accounted for the largest share of the operating room integration applications market in 2018
The general surgery segment accounted for the largest share of the operating room integration market, by application, in 2018. Factors such as the increasing incidence of breast cancer, colorectal cancer, liver cancer, GI disorders, and endocrine disorders as well as the rising number of general surgical procedures performed worldwide are driving the growth of this segment.
Hospitals are the largest end users of the operating room integration market
In 2018, the hospitals segment accounted for the largest share of the operating room integration market. The large share of this segment can be attributed to the rising patient emphasis on timely and effective disease management, rising number of diagnostic and surgical procedures carried out at hospitals, and the increasing number of hospitals being set up in developing countries.
North America to dominate the operating room integration market during the forecast period
In 2018, North America accounted for the largest share of the operating room integration market, followed by Europe. In the US, the operating room integration market is driven by the need to curtail soaring healthcare costs, increasing patient preference for minimally invasive surgeries (owing to their procedural benefits such as lower risk of surgical-site infections, decreased patient injuries, and shorter hospitalization times), rising adoption rate of integrated operating rooms among healthcare providers, and increasing number of ambulatory surgery centers. According to the CMS, in 2016, healthcare spending in the US was estimated at USD 3.4 trillion, and this figure is estimated to reach USD 5.7 trillion by 2026. During 2017–2026, healthcare spending in the US is expected to rise by 5.5% annually.
Moreover, growth in the Canadian operating room integration market is mainly driven by the adoption of technologically advanced HCIT solutions, the need for healthcare cost containment, and initiatives to increase the adoption of integrated OR solutions.
Prominent players in the operating room integration market are Stryker Corporation (US), STERIS (US), KARL STORZ (Germany), Olympus (Japan), Getinge (Sweden), Alvo Medical (Poland), Skytron (US), Merivaara (Finland), Brainlab (Germany), TRILUX Medical (Germany), caresyntax (US), Sony (Japan), Barco (Belgium), Arthrex (US), and Richard Wolf (Germany).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
